NCT04969679View on ClinicalTrials.gov

Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

March 16, 2018

Primary Completion Date

June 3, 2020

Study Completion Date

June 3, 2020

Conditions
Ulcerative Colitis
Interventions
DRUG

E. coli Nissle 1917 (Mutaflor®)

Take 1 capsule per day in the morning from the first day to the fourth day and take 2 capsules per day from the fifth day to the end of the testing period.(for 8 weeks)

DRUG

Placebo

Take 1 capsule per day in the morning from the first day to the fourth day and take 2 capsules per day from the fifth day to the end of the testing period.(for 8 weeks)

Trial Locations (1)

Unknown

Soo-kyung Park, Seoul

All Listed Sponsors
lead

Kangbuk Samsung Hospital

OTHER

NCT04969679 - Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment. | Biotech Hunter | Biotech Hunter